Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade.
Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, Engle JW, Le T, Kim K, Bednarz B, Sondel PM, Weichert J, Morris ZS. Patel RB, et al. Among authors: grudzinski j. Sci Transl Med. 2021 Jul 14;13(602):eabb3631. doi: 10.1126/scitranslmed.abb3631. Sci Transl Med. 2021. PMID: 34261797 Free PMC article.
Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors.
Potluri HK, Ferreira CA, Grudzinski J, Massey C, Aluicio-Sarduy E, Engle JW, Kwon O, Marsh IR, Bednarz BP, Hernandez R, Weichert JP, McNeel DG. Potluri HK, et al. Among authors: grudzinski j. J Immunother Cancer. 2022 Aug;10(8):e005060. doi: 10.1136/jitc-2022-005060. J Immunother Cancer. 2022. PMID: 36002185 Free PMC article.
Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.
Magee K, Marsh IR, Turek MM, Grudzinski J, Aluicio-Sarduy E, Engle JW, Kurzman ID, Zuleger CL, Oseid EA, Jaskowiak C, Albertini MR, Esbona K, Bednarz B, Sondel PM, Weichert JP, Morris ZS, Hernandez R, Vail DM. Magee K, et al. Among authors: grudzinski j. PLoS One. 2021 Aug 12;16(8):e0255798. doi: 10.1371/journal.pone.0255798. eCollection 2021. PLoS One. 2021. PMID: 34383787 Free PMC article.
Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy.
Weichert JP, Clark PA, Kandela IK, Vaccaro AM, Clarke W, Longino MA, Pinchuk AN, Farhoud M, Swanson KI, Floberg JM, Grudzinski J, Titz B, Traynor AM, Chen HE, Hall LT, Pazoles CJ, Pickhardt PJ, Kuo JS. Weichert JP, et al. Among authors: grudzinski j. Sci Transl Med. 2014 Jun 11;6(240):240ra75. doi: 10.1126/scitranslmed.3007646. Sci Transl Med. 2014. PMID: 24920661 Free PMC article.
Current Status of Radiopharmaceutical Therapy.
St James S, Bednarz B, Benedict S, Buchsbaum JC, Dewaraja Y, Frey E, Hobbs R, Grudzinski J, Roncali E, Sgouros G, Capala J, Xiao Y. St James S, et al. Among authors: grudzinski j. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):891-901. doi: 10.1016/j.ijrobp.2020.08.035. Epub 2020 Aug 14. Int J Radiat Oncol Biol Phys. 2021. PMID: 32805300 Free PMC article. Review.
Toward Individualized Voxel-Level Dosimetry for Radiopharmaceutical Therapy.
Xiao Y, Roncali E, Hobbs R, James SS, Bednarz B, Benedict S, Dewaraja YK, Frey E, Grudzinski J, Sgouros G, Buchsbaum JC, Capala J. Xiao Y, et al. Among authors: grudzinski j. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):902-904. doi: 10.1016/j.ijrobp.2020.08.026. Int J Radiat Oncol Biol Phys. 2021. PMID: 33610302 Free PMC article. No abstract available.
44 results